Serum hyaluronan and hyaluronidase: Very early markers of toxic liver injury

Clinica Chimica Acta

Volumn 348, Issue 1-2, 2004, Pages 189-197

  George, Joseph ^a   Stern, Robert ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cirrhosis; Dimethylnitrosamine; Hyaluronan; Hyaluronidase; Toxic liver injury

Indexed keywords

AMINOTRANSFERASE; BIOLOGICAL MARKER; DIMETHYLNITROSAMINE; HYALURONIC ACID; HYALURONIDASE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; LIVER; LIVER CELL; LIVER CONGESTION; LIVER HEMORRHAGE; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; MALE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; TISSUE SECTION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BODY WEIGHT; DIMETHYLNITROSAMINE; HEPATITIS, TOXIC; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; INJECTIONS, INTRAPERITONEAL; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; ORGAN SIZE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 4444255560     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.05.018     Document Type: Article

References (74)

1. Haggerty H.G., Holsapple M.P. Role of metabolism in dimethylnitrosamine induced immunosuppression: a review. Toxicology. 63:1990;1-23
2. Barnes J.M., Magee P.N. Some toxic properties of dimethylnitrosamine. Br. J. Ind. Med. 11:1954;167-174
3. Yang C.S., Tu Y.Y., Koop D.R., Coon M.J. Metabolism of nitrosamines by purified liver cytochrome P-450. Cancer Res. 45:1985;1140-1145
4. Yang C.S., Yoo J.S.H., Ishizaki H., Hong J. Cytochrome P450IIE1: role in nitrosamine metabolism and mechanisms of regulation. Drug Metab. 22:1900;147-159
5. Yoo J.S.H., Guengerich F.P., Yang C.S. Metabolism of N- nitrosodialkylamines by human liver microsomes. Cancer Res. 88:1988;1499-1504
6. Laurent T.C., Laurent U.B.G., Fraser J.R.E. Serum hyaluronan as a disease marker. Ann. Med. 28:1996;241-253
7. Laurent T.C. The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives. 1998;Portland Press, London
8. Toole B.P. Proteoglycans and hyaluronan in morphogenesis and differentiation. Hay E.D. Cell Biology of Extracellular Matrix. 1991;305-341 Plenum Press, New York
9. Toole B.P. Hyaluronan is not just goo! J. Clin. Invest. 106:2000;335-337
10. Fraser J.R., Laurent T.C., Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 242:1997;27-33
11. Lee J.Y., Spicer A.P. Hyaluronan: a multifunctional megaDalton stealth molecule. Curr. Opin. Cell Biol. 12:2000;581-586
12. Berg S. Hyaluronan turnover in relation to infection and sepsis. J. Intern. Med. 242:1997;73-77
13. Berg S., Brodin B., Hesselvik F., Laurent T.C., Maller R. Elevated levels of plasma hyaluronan in septicaemia. Scand. J. Clin. Lab. Invest. 48:1988;727-732
14. Ferrara J.J., Reed R.K., Dyess D.L., Townsley M.I., Onarheim H., Laurent T.C., et al. Increased hyaluronan flux from skin following burn injury. J. Surg. Res. 50:1991;240-244
15. Onarheim H., Missavage A.E., Gunther R.A., Kramer G.C., Reed R.K., Laurent T.C. Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J. Surg. Res. 50:1991;259-265
16. Onarheim H., Reed R.K., Laurent T.C. Increased plasma concentrations of hyaluronan after major thermal injury in the rat. Circ. Shock. 37:1992;159-163
17. Granger H.J., Laine G.A., Barnes G.E., Lewis R.E. Dynamics and control of transmicrovascular fluid exchange. Staub N.C., Taylor A.E. Edema. 1984;189-228 Raven Press, New York
18. Postlethwaite A.E., Smith G.N. Jr., Lachman L.B., Endres R.O., Poppleton H.M., Hasty K.A., et al. Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171. J. Clin. Invest. 83:1989;629-636
19. Ohkawa T., Ueki N., Taguchi T., Shindo Y., Adachi M., Amuro Y., et al. Stimulation of hyaluronan synthesis by tumor necrosis factor-alpha is mediated by the p50/p65 NF-kappa B complex in MRC-5 myofibroblasts. Biochim. Biophys. Acta. 1448:1999;416-424
20. Engstrom-Laurent A., Loof L., Nyberg A., Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology. 5:1985;638-642
21. Nyberg A., Engstrom-Laurent A., Loof L. Serum hyaluronate in primary biliary cirrhosis - a biochemical marker for progressive liver damage. Hepatology. 8:1988;142-146
22. Mattsson L., Lindqvist U., Weiland O., Aber B. Serum levels of the aminoterminal propeptide of type III procollagen and hyaluronan during resolving and nonresolving posttransfusion non-A, non-B hepatitis. Scand. J. Infect. Dis. 22:1990;11-17
23. Ramadori G., Zohrens G., Manns M., Rieder H., Dienes H.P., Hess G., et al. Serum hyaluronate and type III procollagen aminoterminal propeptide concentratio in chronic liver disease. Relationship to cirrhosis and disease activity. Eur. J. Clin. Invest. 21:1991;323-330
24. Trivedi P., Cheeseman P., Mowat A.P. Serum hyaluronic acid in healthy infants and children and its value as a marker of progressive hepatobiliary disease starting in infancy. Clin. Chim. Acta. 215:1993;29-33
25. Frebourg T., Delpech B., Bercoff E., Senant J., Bertrand P., Deugnier Y., et al. 1. Serum hyaluronate in liver diseases: study by enzymo-immunological assay. Hepatology. 6:1986;392-395
26. Kobayashi H., Horikoshi K., Yamataka A., Yamataka T., Okazaki T., Lane G.J., et al. Hyaluronic acid: a specific prognostic indicator of hepatic damage in biliary atresia. J. Pediatr. Surg. 34:1999;1791-1794
27. Guechot J., Serfaty L., Bonnand A.M., Chazouilleres O., Poupon R., Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J. Hepatol. 32:2000;447-452
28. Nanji A.A., Tahan R., Khwaja S., Yacoub L.K., Sadrzadeh S.M. Elevated plasma levels of hyaluronic acid indicate endothelial cell dysfunction in the initial stages of alcoholic liver disease in the rat. J. Hepatol. 24:1996;368-374
29. Rao P.N., Bronsther O.L., Pinna A.D., Demetris A., Snyder J., Fung J., et al. Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. Transplant. Proc. 25:1993;2141-2142
30. Rao P.N., Bronsther O.L., Pinna A.D., Snyder J.T., Cowan S., Sankey S., et al. Hyaluronate levels in donor organ washout effluents: a simple and predictive parameter of graft viability. Liver. 16:1996;48-54
31. Lendoire J.C., Duek F., Bianco G., Aziz H., Saul J., Blanco S., et al. Correlation between effluent hyaluronic acid levels and early graft function in orthotopic liver transplantation. Transplant. Proc. 30:1998;2889-2890
32. Fabrega E., Castro B., Crespo J., de la Pena J., Gomez-Fleitas M., Garcia-Unzueta M.T., et al. Different time course of circulating adhesion molecules and hyaluran during hepatic allograft rejection. Transplantation. 69:2000;569-573
33. Vrochides D., Papanikolaou V., Pertoft H., Antoniades A.A., Heldin P. Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration. Hepatology. 23:1996;1650-1655
34. Gressner A.M., Haarmann R. Regulation of hyaluronate synthesis in rat liver fat storing cell cultures by Kupffer cells. J. Hepatol. 7:1988;310-318
35. Eriksson S., Fraser J.R., Laurent T.C., Pertoft H., Smedsrod B. Endothelial cells are sites of uptake and degradation of hyaluronic acid in the liver. Exp. Cell Res. 144:1983;223-228
36. Fraser J.R., Alcorn D., Laurent T.C., Robinson A.D., Ryan G.B. Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Res. 242:1985;505-510
37. Csoka A.B., Frost G.I., Stern R. The six hyaluronidase-like sequences in the human genome. Matrix. 20:2001;499-508
38. Frost G.I., Csoka T.B., Wong T., Stern R. Purification, cloning and expression of human plasma hyaluronidase. Biochem. Biophys. Res. Commun. 236:1997;10-15
39. Csóka T.B., Frost G.I., Wong T., Stern R. Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett. 417:1997;307-310
40. Fraser J.R., Laurent T.C., Pertoft H., Baxter E. Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem. J. 200:1981;415-424
41. Weigel P.H., Hascall V.C., Tammi M. Hyaluronan synthases. J. Biol. Chem. 272:1997;13997-14000
42. Jenkins S.A., Grandison A., Baxter J.N., Day D.W., Taylor I., Shields R. A dimethylnitrosamine induced model of cirrhosis and portal hypertension in the rat. J. Hepatol. 1:1985;489-499
43. Ala-Kokko L., Pihlajaniemi T., Myers J.C., Kivirikko K.I., Savolainen E.R. Gene expression of types I, III, and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem. J. 24:1987;75-79
44. Savolainen E.R., Brocks D., Ala-Kokko L., Kivirikko K.I. Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis. Biochem. J. 249:1988;753-757
45. George J., Chandrakasan G. Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats. Int. J. Biochem. Cell Biol. 28:1996;353-361
46. George J., Chandrakasan G. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochim. Biophys. Acta. 1292:1996;215-222
47. George J., Chandrakasan G. Lactate dehydrogenase isoenzymes in dimethylnitrosamine-induced hepatic fibrosis in rats. J. Clin. Biochem. Nutr. 22:1997;51-62
48. George J., Chandrakasan G. Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clin. Biochem. 33:2000;563-570
49. George J., Rao K.R., Stern R., Chandrakasan G. Dimethylnitrosamine- induced liver injury in rats: the early deposition of collagen. Toxicology. 156:2001;129-138
50. Weigel P.H., Fuller G.M., LeBoeuf R.D. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J. Theor. Biol. 119:1986;219-234
51. Weigel P.H., Frost S.J., McGary C.T., LeBoeuf R.D. The role of hyaluronic acid in inflammation and wound healing. Int. J. Tissue React. 10:1988;355-365
52. Longaker M.T., Chiu E.S., Adzick N.S., Stern M., Harrison M.R., Stern R. Studies in fetal wound healing: V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann. Surg. 213:1991;292-296
53. Fosang A.J., Hey N.J., Carney S.L., Hardingham T.E. An ELISA plate based assay for hyaluronan using biotinylated proteoglycan G1 domain (HA-binding region). Matrix. 10:1990;306-313
54. Frost G.I., Stern R. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal. Biochem. 251:1997;263-269
55. Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding properties from cartilage. Biochim. Biophys. Acta. 578:1979;281-289
56. Meyer L.J., Russell S.B., Russell J.D., Trupin J.S., Egbert B.M., Shuster S., et al. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J. Invest. Dermatol. 114:2000;953-959
57. Lin W., Shuster S., Maibach H.I., Stern R. Patterns of hyaluronan staining are modified by fixation techniques. J. Histochem. Cytochem. 45:1997;1157-1163
58. Hashimoto N., Ishikawa Y., Utsunomiya J. Effects of portacaval shunt, transposition, and dimethylnitrosamine-induced chronic liver injury on pancreatic hormones and amino acids in dog. J. Surg. Res. 46:1989;35-40
59. Magee P.N., Barnes J. Carcinogenic nitroso compounds. Adv. Cancer Res. 10:1967;163-246
60. Magee P.N. The experimental basis for the role of nitroso compounds in human cancer. Cancer Surv. 8:1989;207-239
61. Tsutsumi M., Matsuda Y., Takada A. Role of ethanol-inducible cytochrome P-4502E1 in the development of hepatocellular carcinoma by the chemical carcinogen, N-nitrosodimethylamine. Hepatology. 18:1993;1483-1489
62. Evanko S.P., Wight T.N. Intracellular location of hyaluronan in proliferating cells. J. Histochem. Cytochem. 47:1999;1331-1342
63. Evanko S.P., Angello J.C., Wight T.N. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;1004-1013
64. Tammi R., Rilla K., Pienimaki J.P., MacCallum D.K., Hogg M., Luukkonen M., et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J. Biol. Chem. 276:2001;35111-35122
65. Majors A.K., Austin R.C., de la Motte C.A., Pyeritz R.E., Hascall V.C., Kessler S.P., et al. Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J. Biol. Chem. 278:2003;47223-47231
66. Chowdhury S.A., Taylor R. Insulin sensitivity in experimental cirrhosis. Mol. Cell. Biochem. 89:1989;69-72
67. Smedsrod B., Pertoft H., Eriksson S., Fraser J.R., Laurent T.C. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem. J. 223:1984;617-626
68. Satoh T., Ichida T., Matsuda Y., Sugiyama M., Yonekura K., Ishikawa T., et al. Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis. J. Gastroenterol. Hepatol. 15:2000;402-411
69. Zhou B., Oka J.A., Singh A., Weigel P.H. Purification and subunit characterization of the rat liver endocytic hyaluronan receptor. J. Biol. Chem. 274:1999;33831-33834
70. Zhou B., Weigel J.A., Fauss L., Weigel P.H. Identification of the hyaluronan receptor for endocytosis. J. Biol. Chem. 275:2000;37733-37734
71. Engstrom-Laurent A., Hellstrom S. The role of liver and kidneys in the removal of circulating hyaluronan. An experimental study in the rat. Connect. Tissue Res. 24:1990;219-224
72. Csóka T.B., Frost G.I., Heng H.H., Scherer S.W., Mohapatra G., Stern R. The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus. Genomics. 48:1998;63-70
73. Lepperdinger G., Mullegger J., Kreil G. Hyal2-less active, but more versatile? Biology. 20:2001;509-514
74. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology. 13:2003;105R-115R